Видео ютуба по тегу Nsclc Egfr

Понимание лечения НМРЛ при наличии мутации EGFR
Понимание лечения НМРЛ при наличии мутации EGFR
Сложные случаи метастатического немелкоклеточного рака легких с мутацией EGFR с доктором Эриком С...
Сложные случаи метастатического немелкоклеточного рака легких с мутацией EGFR с доктором Эриком С...
FLAURA2 outcomes by EGFR mutation subtype in advanced NSCLC
FLAURA2 outcomes by EGFR mutation subtype in advanced NSCLC
Case #2: Treating a Patient with Stage IV NSCLC with EGFR - 2025 Case Based Panel Discussions
Case #2: Treating a Patient with Stage IV NSCLC with EGFR - 2025 Case Based Panel Discussions
Multimodal Management of Early-Stage NSCLC: EGFR-Targeted Therapy in Perioperative Settings
Multimodal Management of Early-Stage NSCLC: EGFR-Targeted Therapy in Perioperative Settings
Overcoming EGFR-TKI resistance: Emerging therapies and biomarker strategies in NSCLC
Overcoming EGFR-TKI resistance: Emerging therapies and biomarker strategies in NSCLC
Что такое мутация EGFR при раке легких?
Что такое мутация EGFR при раке легких?
Clinical Care of Patients with EGFR Mutation-Positive Non-Small Cell Lung Cancer
Clinical Care of Patients with EGFR Mutation-Positive Non-Small Cell Lung Cancer
Therapy for EGFR Classical Mutation in NSCLC - 2025 Targeted Therapies in Lung Cancer Patient Forum
Therapy for EGFR Classical Mutation in NSCLC - 2025 Targeted Therapies in Lung Cancer Patient Forum
Advances in Managing EGFR-Mutant NSCLC: Applying Evidence Across the Disease Continuum
Advances in Managing EGFR-Mutant NSCLC: Applying Evidence Across the Disease Continuum
The impact of p53 mutation on survival in EGFR-mutated NSCLC patients
The impact of p53 mutation on survival in EGFR-mutated NSCLC patients
NSCLC: EGFR Inhibition and Resistance Mechanisms
NSCLC: EGFR Inhibition and Resistance Mechanisms
EGFR Resisters Welcome Video: How We Can Help with EGFR+ NSCLC
EGFR Resisters Welcome Video: How We Can Help with EGFR+ NSCLC
Safety of osimertinib plus tegavivint in first-line EGFR-mutant NSCLC
Safety of osimertinib plus tegavivint in first-line EGFR-mutant NSCLC
Finding the Optimal Treatment for EGFR-mutated Metastatic NSCLC
Finding the Optimal Treatment for EGFR-mutated Metastatic NSCLC
EGFR-Mutant Lung Cancer & Treatment Options | 2023 Living with EGFR-Mutant Lung Cancer Patient Forum
EGFR-Mutant Lung Cancer & Treatment Options | 2023 Living with EGFR-Mutant Lung Cancer Patient Forum
Volumetric Response of Brain Metastases in EGFR mutant NSCLC | Lisa Ni, MD
Volumetric Response of Brain Metastases in EGFR mutant NSCLC | Lisa Ni, MD
Osimertinib after surgery significantly improves survival in resected EGFR-mutated NSCLC
Osimertinib after surgery significantly improves survival in resected EGFR-mutated NSCLC
NSCLC With EGFR Exon 20 Shows Benefit With Mobocertinib Over Chemotherapy
NSCLC With EGFR Exon 20 Shows Benefit With Mobocertinib Over Chemotherapy
Advancements of Targeted Therapy for EGFR Mutations in NSCLC
Advancements of Targeted Therapy for EGFR Mutations in NSCLC